News
The following is a summary of “Risk of severe bacterial infections including TB before and after immediate or deferred ...
6d
NEUVOGEN, Inc. ("NEUVOGEN THERAPEUTICS" or "NEUVOGEN"), a San Diego based biotechnology company, will present data that its next generation whole tumor cell vaccine (NGEN-143) activates T cells that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback